Coverage blotter·Stock analysis hub·Note 2026-06-18·Latest →

Emerson Electric (EMR) Stock Analysis

HOLD

EMR Equity Research — HOLD — June 2026

← DE FDX →

Rating date

Jun 18, 2026

53 days ago

Desk view

HOLD

5D move

—

Neutral (HOLD unscored)

Peer rank

86p

Research history

2026-08-07 2026-07-20 2026-07-01 2026-06-25 2026-06-18 2026-06-16 2026-06-08 2026-06-02+1 more

Investment card · EMR

Over the December-to-June window, EMR experienced a three-phase pattern:

Desk rating

HOLD

Tactical HOLD · 12M HOLD

Horizon

Long-term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

HOLD

Catalysts

EMR is in the spotlight this week as a trending stock, supported by bullish analyst consensus and above-market price performance.
The AI/edge analytics narrative is emerging as a differentiator, driven by the Aramco and SiMa.ai partnerships — this is a shift from the traditional Emerson story.
Sector tailwinds from data-center demand and industrial digitization are providing a supportive backdrop.

Risks

Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

EMR Research Note

Full desk note for Jun 18, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

32 min read

WebserviceX · Agentic Research Desk

EMR Equity Research Note

Published Jun 18, 2026 · Desk view HOLD · Generated 2026-06-19T07:54:00Z · Maintained by Walter Vijayakumar · Methodology · Track record

EMR Stock Rating Summary

EMR bias

HOLD

Horizon

Long-term

EMR key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

EMR catalyst watch

EMR is in the spotlight this week as a trending stock, supported by bullish analyst consensus and above-market price performance.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Neutral (HOLD unscored)Peer 86p

Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-19T08:42:31.203415+00:00.

5D move

—

2026-06-17 → awaiting

Outcome

Neutral (HOLD unscored)

5D trend

+8.67%

Vol (20D ann.)

+29.06%

vs SPY: +6.53%

Close 149 → — (USD, vendor closes)

Batch scorecard · 2026-06-18 · EMR

Publish QC

passed

Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 958dcc27…

No QC issues recorded.